Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: Effects of long-term continuous positive airway pressure.

[1]  J. Pépin,et al.  Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials. , 2015, Sleep medicine reviews.

[2]  L. Lavie.  Oxidative stress in obstructive sleep apnea and intermittent hypoxia--revisited--the bad ugly and good: implications to the heart and brain. , 2015, Sleep medicine reviews.

[3]  Chi-Ling Chen,et al.  Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis , 2014, Sleep and Breathing.

[4]  S. Yin,et al.  Effect of continuous positive airway pressure on lipid profile in patients with obstructive sleep apnea syndrome: a meta-analysis of randomized controlled trials. , 2014, Atherosclerosis.

[5]  W. Kong,et al.  The Differences in Homocysteine Level between Obstructive Sleep Apnea Patients and Controls: A Meta-Analysis , 2014, PloS one.

[6]  M. Montagnana,et al.  Effect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis. , 2014, Chest.

[7]  W. Kong,et al.  Effect of continuous positive airway pressure on homocysteine levels in patients with obstructive sleep apnea: a meta-analysis , 2014, Sleep and Breathing.

[8]  S. Solomon,et al.  Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study. , 2013, American journal of respiratory and critical care medicine.

[9]  P. Nilsson,et al.  Practice guidelines for themanagement of arterial hypertension of the European Society of Hypertension ( ESH ) and the European Society of Cardiology ( ESC ) ESH / ESCTask Force for theManagement of Arterial Hypertension , 2018 .

[10]  V. Polotsky,et al.  Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. , 2013, Journal of the American College of Cardiology.

[11]  J. Pépin,et al.  The Severity of Nocturnal Hypoxia but Not Abdominal Adiposity Is Associated with Insulin Resistance in Non-Obese Men with Sleep Apnea , 2013, PloS one.

[12]  I. Iftikhar,et al.  Meta-analysis: continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes. , 2013, Annals of the American Thoracic Society.

[13]  Dan Yang,et al.  Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis , 2013, Sleep and Breathing.

[14]  Gilles Barone-Rochette,et al.  Mechanisms of cardiac dysfunction in obstructive sleep apnea , 2012, Nature Reviews Cardiology.

[15]  K. Wroblewski,et al.  Obstructive Sleep Apnea in Young Lean Men , 2012, Diabetes Care.

[16]  Dan Yang,et al.  The impact of effective continuous positive airway pressure on homeostasis model assessment insulin resistance in non‐diabetic patients with moderate to severe obstructive sleep apnea , 2012, Diabetes/metabolism research and reviews.

[17]  L. Murri,et al.  Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. , 2012, Sleep medicine.

[18]  J. Pépin,et al.  The impact of obstructive sleep apnea on homocysteine and carotid remodeling in metabolic syndrome , 2012, Respiratory Physiology & Neurobiology.

[19]  D. Jassal,et al.  Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. , 2012, Chest.

[20]  G. Meyer,et al.  Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis , 2011, German medical science : GMS e-journal.

[21]  E. Vlachogiannis,et al.  Total antioxidant status in patients with obstructive sleep apnea without comorbidities: the role of the severity of the disease , 2011, Sleep and Breathing.

[22]  E. Maltezos,et al.  Continuous positive airway pressure treatment in patients with sleep apnoea: does it really improve glucose metabolism? , 2010, Current diabetes reviews.

[23]  D. Jassal,et al.  Obstructive sleep apnea: effects of continuous airway pressure on cardiac remodeling as assessed by cardiac MRI , 2010 .

[24]  Adelaide M. Arruda-Olson,et al.  Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun , 2008, Journal of the American College of Cardiology.

[25]  C. Hürny,et al.  N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea , 2008, Sleep and Breathing.

[26]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[27]  B. Zinman,et al.  Impaired Fasting Glucose and Impaired Glucose Tolerance , 2007, Diabetes Care.

[28]  W. McNicholas,et al.  Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity , 2007, Thorax.

[29]  D. Levy,et al.  Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample. , 2006, Sleep.

[30]  A. Agustí,et al.  Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment , 2006, European Respiratory Journal.

[31]  L. Juncos,et al.  Oxidative stress in obstructive sleep apnoea. , 2005, European heart journal.

[32]  L. Køber,et al.  N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. , 2005, The New England journal of medicine.

[33]  G. Lamas,et al.  Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. , 2004, American heart journal.

[34]  J. Kornhuber,et al.  CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome , 2004, Journal of Neural Transmission.

[35]  K. Lam,et al.  Obstructive sleep apnea is independently associated with insulin resistance. , 2002, American journal of respiratory and critical care medicine.

[36]  Andrea Mari,et al.  A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test , 2001 .

[37]  S. Vollset,et al.  The controversy over homocysteine and cardiovascular risk. , 2000, The American journal of clinical nutrition.

[38]  W. Flemons,et al.  Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research , 1999 .

[39]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[40]  S. Dzięgielewska-Gęsiak,et al.  Blood antioxidant status, dysglycemia and obstructive sleep apnea. , 2013, Advances in experimental medicine and biology.

[41]  L. Lavie.  Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea. , 2012, Frontiers in bioscience.

[42]  L. Lavie,et al.  Oxidative stress--a unifying paradigm in obstructive sleep apnea and comorbidities. , 2009, Progress in cardiovascular diseases.

[43]  A. Favier,et al.  A robust liquid chromatography tandem mass spectrometry method for total plasma homocysteine determination in clinical practice , 2006, Clinical chemistry and laboratory medicine.

[44]  L. Flohé,et al.  An Improved Coupled Test Procedure for Glutathione Peroxidase (EC 1.11.1.9.) in Blood , 1974, Zeitschrift fur klinische Chemie und klinische Biochemie.